Rifampicin cost-effective option for LTBI control
- 期刊名称PharmacoEconomics & Outcomes News
- 作者Huttegger, Simon M.; Skyrms, Brian; Zollman, Kevin J. S.
- 卷第674卷
- 期第1期
- 印刷ISSN1173-5503
- 电子ISSN1179-2043
- 文件大小114.82KB
- 发表时间2013-03
- DOI10.1007/s40274-013-0252-6
- 页码8-8
SulfasalazineMoriyasu, T.; Wakabayashi, S.; Kohmoto, T. · Reactions Weekly · 2013
UstekinumabMoriyasu, T.; Wakabayashi, S.; Kohmoto, T. · Reactions Weekly · 2013
Antithymocyte globulin/insulinsMoriyasu, T.; Wakabayashi, S.; Kohmoto, T. · Reactions Weekly · 2013
Cisplatin/fluorouracilMoriyasu, T.; Wakabayashi, S.; Kohmoto, T. · Reactions Weekly · 2013
TocilizumabMoriyasu, T.; Wakabayashi, S.; Kohmoto, T. · Reactions Weekly · 2013
ErlotinibMoriyasu, T.; Wakabayashi, S.; Kohmoto, T. · Reactions Weekly · 2013
AntiretroviralsMoriyasu, T.; Wakabayashi, S.; Kohmoto, T. · Reactions Weekly · 2013
ImatinibMoriyasu, T.; Wakabayashi, S.; Kohmoto, T. · Reactions Weekly · 2013
Biperiden/trihexyphenidylReactions Weekly · 1995
NitrendipineReactions Weekly · 2003
ScopolamineReactions Weekly · 2007
ScopolamineReactions Weekly · 2012
ScopolamineReactions Weekly · 2009
Centella asiaticaReactions Weekly · 2011
Daunorubicin/mitoxantroneReactions Weekly · 2007
AnthracyclinesReactions Weekly · 1991